Publications by authors named "Vivasvan Vykunta"

Claim this Profile
S
SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple loci.
Christopher R Chang, Vivasvan S Vykunta, Jae Hyun J Lee, Ke Li, Clara Kochendoerfer

Nat Biotechnol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Submicron-Sampling of Living Cells by Macrophages.
Amy C Fan, Rukman Thota, Nina Serwas, Vivasvan S Vykunta, Kyle Marchuk

bioRxiv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered cancer metabolism and implications for next-generation CAR T-cell therapies.
Rishab Ramapriyan, Vivasvan S Vykunta, Gust Vandecandelaere, Leland G K Richardson, Jing Sun

Pharmacol Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mast cells help organize the Peyer's patch niche for induction of IgA responses.
Marco De Giovanni, Vivasvan S Vykunta, Adi Biram, Kevin Y Chen, Hanna Taglinao

Sci Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultra-high efficiency T cell reprogramming at multiple loci with SEED-Selection.
Christopher R Chang, Vivasvan S Vykunta, Daniel B Goodman, Joseph J Muldoon, William A Nyberg

bioRxiv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular basis for potent B cell responses to antigen displayed on particles of viral size.
Jeremy F Brooks, Julianne Riggs, James L Mueller, Raisa Mathenge, Wei-Yun Wholey, Vivasvan S Vykunta

Nat Immunol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes.
Dana V Foss, Joseph J Muldoon, David N Nguyen, Daniel Carr, Srishti U Sahu, Vivasvan S Vykunta

Nat Biomed Eng· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails.
Brian R Shy, Vivasvan S Vykunta, Alvin Ha, Alexis Talbot, Theodore L Roth

Nat Biotechnol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular basis for potent B cell responses to antigen displayed on particles of viral size.
Jeremy F Brooks, Julianne Riggs, James L Mueller, Raisa Mathenge, Wei-Yun Wholey, Vivasvan S Vykunta

bioRxiv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic phosphatase-recruitment controls B-cell selection and oncogenic signaling.
Jaewoong Lee, Mark E Robinson, Ruifeng Sun, Kohei Kume, Ning Ma, Vivasvan S Vykunta

bioRxiv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies.
Daniel B Goodman, Camillia S Azimi, Kendall Kearns, Alexis Talbot, Kiavash Garakani, Vivasvan S Vykunta

Sci Transl Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR-Cas9-mediated nuclear transport and genomic integration of nanostructured genes in human primary cells.
Enrique Lin-Shiao, Wolfgang G Pfeifer, Brian R Shy, Mohammad Saffari Doost, Evelyn Chen, Vivasvan S Vykunta

Nucleic Acids Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Negative feedback by NUR77/Nr4a1 restrains B cell clonal dominance during early T-dependent immune responses.
Jeremy F Brooks, Corey Tan, James L Mueller, Kenta Hibiya, Ryosuke Hiwa, Vivasvan Vykunta

Cell Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NR4A nuclear receptors restrain B cell responses to antigen when second signals are absent or limiting.
Corey Tan, Ryosuke Hiwa, James L Mueller, Vivasvan Vykunta, Kenta Hibiya

Nat Immunol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Development of Mature B Cells Requires Recognition of Endogenous Antigens.
Mark Noviski, Corey Tan, John Huizar, Vivasvan Vykunta, James L Mueller

J Immunol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis